China Regulatory Scrutiny Will Curb Margins But Hope Remains

AN
AnalystLowTarget
AnalystLowTarget
Not Invested
Consensus Narrative from 3 Analysts
Published
12 Jul 25
Updated
24 Jul 25
AnalystLowTarget's Fair Value
US$2.90
26.9% undervalued intrinsic discount
24 Jul
US$2.12
Loading
1Y
15.8%
7D
-2.3%

Author's Valuation

US$2.9

26.9% undervalued intrinsic discount

AnalystLowTarget Fair Value